Merck & Co., Inc. (NYSE:MRK) is one of the best wide moat stocks to buy now. On June 9, Merck’s…
Read More »RSV
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca CNBC Merck Says It Wins US Approval…
Read More »U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born…
Read More »A one-time antibody injection against RSV is available for infants in some countries Shutterstock / Anatta_Tan An antibody treatment for…
Read More »According to UN Children’s Fund, UNICEF, more than 290 schools have been damaged or destroyed in Ituri this year alone,…
Read More »WHO outlines recommendations to protect infants against RSV – respiratory syncytial virus World Health Organization (WHO) Key Takeaways to Prioritize in…
Read More »